Tumor Necrosis Factor-α Supports the Survival of Osteoclasts through the Activation of Akt and ERK

This publication has 52 references indexed in Scilit:

• Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
  Endocrine Reviews, 1999
• Activation of NF-κB by RANK Requires Tumor Necrosis Factor Receptor-associated Factor (TRAF) 6 and NF-κB-inducing Kinase
  Published by Elsevier ,1999
• Receptor activator of NF‐κB recruits multiple TRAF family adaptors and activates c‐Jun N‐terminal kinase
  FEBS Letters, 1999
• Transforming Growth Factor-β1 Increases mRNA Levels of Osteoclastogenesis Inhibitory Factor in Osteoblastic/Stromal Cells and Inhibits the Survival of Murine Osteoclast-like Cells
  Biochemical and Biophysical Research Communications, 1998
• Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21Ras in IL-3-dependent hematopoietic cells
  Oncogene, 1997
• Calcitonin promotes osteoclast survival in vitro
  Molecular and Cellular Endocrinology, 1996
• Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
  Science, 1995
• A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor
  Cell, 1994
• Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts.
  The Journal of Experimental Medicine, 1993
• Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro
  Journal of Bone and Mineral Research, 1989